Bevacizumab plus Oxaliplatin-Based Regimens for the Treatment of Colorectal Cancer

Publisher： Karger

E-ISSN： 2296-5262|32|7|431-439

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.7, 2009-06, pp. : 431-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 118-128

Karger

Access to resources Recommend Favorite

5-Fluorouracil, Leucovorin and Oxaliplatin plus Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer: A Single-Institute Study

By  

Oncology, Vol. 72, Iss. 1-2, 2007-10 ,pp. : 4-9

Karger

Access to resources Recommend Favorite

Efficacy of Oxaliplatin-Based Chemotherapy in Curatively Resected Colorectal Cancer with Liver Metastasis

By  

Oncology, Vol. 81, Iss. 3-4, 2011-11 ,pp. : 175-183

Karger

Access to resources Recommend Favorite

Bevacizumab Combined with Standard Fluoropyrimidine-Based Chemotherapy Regimens to Treat Colorectal Cancer

By  

Oncology, Vol. 69, Iss. 3, 2005-11 ,pp. : 17-24

Karger

Access to resources Recommend Favorite

Incidence of Cold-Induced Peripheral Neuropathy and Dose Modification of Adjuvant Oxaliplatin-Based Chemotherapy for Patients with Colorectal Cancer

By  

Oncology, Vol. 87, Iss. 3, 2014-07 ,pp. : 167-172

Karger

Access to resources Recommend Favorite